N/A
Completed N=13
Proton Therapy for Unresectable Cancer (CA) of Pancreas
Source: ClinicalTrials.gov NCT00685763 ↗Enrolled (actual)
13
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcomePrimary: Cumulative Incidence of grade3+ Bowel Perforation, Grade 3+ Bleeding (Ocurring Withing 1 Years) and grade4+ Nonhematologic Acute Adverse Events (Limited to Within 90 Days of Treatment Start) — 0 participants
Summary
The purpose of this study is to find out what effects, good and/or bad, proton radiation and chemotherapy has on you and your pancreatic cancer.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cumulative Incidence of grade3+ Bowel Perforation, Grade 3+ Bleeding (Ocurring Withing 1 Years) and grade4+ Nonhematologic Acute Adverse Events (Limited to Within 90 Days of Treatment Start) |
— | — |
| SECONDARY Collect and Analyze Tumor Control Measures |
— | — |
Eligibility Criteria
Inclusion Criteria
Pathologically confirmed adenocarcinoma of the pancreas.
Patients must be medically inoperable or have unresectable disease
Exclusion Criteria
- Evidence of distant metastasis; evidence of metastatic disease in the major viscera (organs), peritoneal seeding and/or ascites.
- Previous irradiation to the abdomen that would compromise the ability to deliver the prescribed treatment.
- Prior surgical resection.
Data sourced from ClinicalTrials.gov (NCT00685763). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.